NCT03425474View on ClinicalTrials.gov

Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

November 10, 2017

Study Completion Date

November 10, 2017

Conditions
Sedation
Interventions
DRUG

Remimazolam Tosilate

Initial dose plus supplemental doses as necessary

DRUG

Propofol

Initial dose plus supplemental doses as necessary

Trial Locations (1)

010

Clinical trial Ethnics Committee of Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03425474 - Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy | Biotech Hunter | Biotech Hunter